Early Phase Cancer Immunotherapy / edited by Sandip Pravin Patel, Razelle Kurzrock.
Contributor(s): Patel, Sandip Pravin., editor literario | Kurzrock, Razelle, editor literario
| SpringerLink (Online service)
Material type: 
E-bookSeries: (Current Cancer Research, 2199-2584); (Medicine (Springer-11650)).Publisher: Cham, Switzerland : Springer International Publishing, 2018Description: 1 recurso en línea (XI, 331 páginas 24 ilustraciones, 15 ilustraciones a color).ISBN: 9783319637570.Subject: Oncología | InmunoterapiaOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC271.I45 E275 2018 EB (Browse shelf(Opens below)) | Acceso electrónico | eBook.08112199 |
Chapter 1 Primer on Cancer Immunotherapy and the Targeting of Native Proteins -- Chapter 2 Pharmacokinetics and Pharmacodynamics of Immunotherapy -- Chapter 3 Immunotherapeutic Biomarkers and Selection Strategies -- Chapter 4 Radiographic Evaluation of Immunotherapy -- Chapter 5 Cellular Therapy -- Chapter 6 Combinatorial Checkpoint Blockade Immunotherapy and Radiation -- Chapter 7 Early Phase Cancer Immunotherapy -- Chapter 8 Immune Checkpoint Combinations with Inflammatory Pathway Modulators -- Chapter 9 Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials -- Chapter 10 Thoracic Immunotherapy.
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
There are no comments on this title.